Rahimpour, Shahab <br/><br/>
A Triple Blinded, Randomized, Placebo-Controlled Clinical Trial to Evaluate the Efficacy and Safety of Oral Vancomycin in Primary Sclerosing Cholangitis: a Pilot Study.  [electronic resource] 

 -  Journal of gastrointestinal and liver diseases : JGLD  Dec 2016 
 - 457-464 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1842-1121 
<br/><br/><label>Standard No.: </label>10.15403/jgld.2014.1121.254.rah  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adult<br/>Aged<br/>Alkaline Phosphatase--blood<br/>Anti-Bacterial Agents--administration & dosage<br/>Biomarkers--blood<br/>Blood Sedimentation<br/>Cholagogues and Choleretics--therapeutic use<br/>Cholangitis, Sclerosing--blood<br/>Drug Therapy, Combination<br/>Female<br/>Humans<br/>Iran<br/>Liver Function Tests<br/>Male<br/>Middle Aged<br/>Pilot Projects<br/>Time Factors<br/>Treatment Outcome<br/>Ursodeoxycholic Acid--therapeutic use<br/>Vancomycin--administration & dosage<br/>Young Adult<br/>gamma-Glutamyltransferase--blood